Progress on chemotherapy for triple negative breast cancer / 中国癌症杂志
China Oncology
; (12): 316-320, 2014.
Article
en Zh
| WPRIM
| ID: wpr-446123
Biblioteca responsable:
WPRO
ABSTRACT
Triple negative breast cancer (TNBC), as a special molecular subtype of breast cancer, is non-responsive to endocrine therapy or commercially available targeted therapy. It is characterized by early recurrence, rapid progression and poor prognosis. This systemic and comprehensive overview was focused on recent progress on molecular subtyping of triple negative breast cancer and its possible clinical value, chemotherapeutic agents and chemotherapy regimens, and combination of chemotherapy with potential molecular targeting agents.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
China Oncology
Año:
2014
Tipo del documento:
Article